Does Zhongshan Ophthalmology Gene Therapy Drug Need Surgical Operation?

• Make an appointment
• Consulting price
• Online consultation

Whether gene therapy drugs of Zhongshan Ophthalmology need surgical operation

With the continuous development of science and technology, gene therapy has become a new method to treat various diseases. As a professional ophthalmic hospital, Zhongshan Ophthalmology Department also began to try gene therapy drugs to treat some vision related genetic diseases. However, for many people, they may have some doubts about whether Zhongshan ophthalmic gene therapy drugs need surgery.

Overview of gene therapy drugs

Gene therapy is a method to treat hereditary diseases by introducing, repairing or replacing defective genes in patients. Gene therapy drugs are usually composed of plasmids, viral vectors, injections and other forms, which deliver the gene substances needed for treatment to the cells of patients to repair defective genes or increase normal genes. The advantage of gene therapy is that it can accurately treat the root causes of diseases, rather than simply alleviate symptoms.

However, gene therapy usually needs to be carried out in the operating room of a hospital. Specifically, surgical procedures include injecting gene therapy drugs into specific parts of patients, or implanting gene substances into cells or tissues of patients by surgical means. Therefore, Zhongshan ophthalmic gene therapy drugs also need surgery.

Application of gene therapy drugs in Zhongshan ophthalmology

In recent years, Zhongshan Ophthalmology Department began to try to apply gene therapy drugs to the treatment of some common ophthalmic genetic diseases, such as retinitis pigmentosa, hereditary optic neuropathy, etc. Based on the characteristics of genetic diseases, gene therapy drugs need to act directly on the eye tissues of patients to achieve the transmission of genetic material. This process needs to be implemented in the operating room to ensure the safety and effectiveness of drugs.

As a professional ophthalmic hospital, Zhongshan Ophthalmology Department has advanced surgical equipment and experienced medical staff, which can ensure the precise injection and implantation of gene therapy drugs. In this way, the application of gene therapy drugs in Zhongshan ophthalmology can be more safe and effective.

Risks and prospects of gene therapy drugs

The introduction of gene therapy drugs undoubtedly brings new treatment options to many patients. However, gene therapy also has certain risks. Because gene therapy involves the intervention of patients' genetic material, some unforeseen side effects may occur. In addition, the cost of gene therapy drugs is high, which may be difficult for some patients to bear.

However, with the continuous progress of science and technology, the prospect of gene therapy has become more promising. Through accurate diagnosis and individualized treatment, gene therapy is expected to help more patients recover their vision and improve their quality of life. Although the current ophthalmic gene therapy drugs in Zhongshan need surgical operation, with the development of technology, it is believed that in the near future, gene therapy may be more simple and convenient.

Summary

To sum up, Zhongshan ophthalmic gene therapy drugs need surgical operation, because gene therapy requires precise injection of genetic substances into the patient's eye tissue to achieve therapeutic effects. As a professional ophthalmic hospital, Zhongshan Ophthalmology Department has relevant surgical equipment and experience, which can ensure the safety and effectiveness of gene therapy. Although gene therapy drugs have certain risks and cost problems, with the continuous development of technology, gene therapy is expected to become an important means of treating genetic diseases.